FRANKFURT (Reuters) - Moderna and Pfizer-BioNTech are in a tight race to launch their COVID-19 vaccines in Europe after both applied for emergency EU approval on Tuesday, though there was uncertainty ...

April 30 (Reuters) - Pfizer Inc (PFE.N), opens new tab and partner BioNTech SE said on Friday they had applied to the European health regulator to extend the marketing authorization for their ...

BRUSSELS — The head of the European Union's executive arm has announced plans for a major contract extension for COVID-19 vaccines with Pfizer stretching to 2023. European Commission President Ursula ...

Pfizer and BioNTech said Wednesday that initial lab tests show that the omicron variant partly escapes protection offered by the companies' two-dose regimen of their COVID-19 vaccine. However, those ...

The fall COVID-19 vaccine season is starting slowly for Pfizer, with U.S. sales of its Comirnaty shots sinking 25% after federal regulators narrowed recommendations on who should get them. Approval of ...

With approval of the updated COVID-19 vaccine coming weeks later than in the past, the fall vaccine season has started slowly, according to Pfizer. The sales of Pfizer’s Comirnaty shots sank 25% after ...